麻风化疗药物研究进展

[1]

LI Honghui, ZHAO Qing, YOU Jiabao, YANG Baoqi, YANG Qing, SHI Zhongxiang, LIU Hong, ZHANG Furen. Clinical analysis of 65 patients with severe adverse drug reactions [J]. China Journal of Leprosy and Skin Diseases, 2023, 39(5): 332-337.

[2]

RAN Delin, ZHANG Zhaoxia, WU Mei, YU Changping, PAN Futang, WANG Na, LI Furong, SHI Zhongxiang, YANG Baoqi. Analysis of Staphylococcus aureus infection status and drug-resistance of MRSA and MSSA in dermatological inpatients from 2018 to 2020 [J]. China Journal of Leprosy and Skin Diseases, 2022, 38(7): 430-433.

[3]

LI Zheng, XU Fengni, LI Wei, ZHANG Jie, WANG Yanlei, WANG Hong, ZHU Bangyong, HU Guanhao. Analysis of leprosy relapsed cases in Guangxi from 2010 to 2020 [J]. China Journal of Leprosy and Skin Diseases, 2022, 38(6): 373-375.

[4]

ZHANG Zhaoxia, WU Weizhi, WANG Guangjin, ZHOU Shengji, YANG Qing, YAN Xiaoxiao, CHEN Mingfei, LI Furong, SHI Zhongxiang. Analysis of bacterial agents distribution and drug-resistance pattern in 571 skin and soft tissue infection inpatients [J]. China Journal of Leprosy and Skin Diseases, 2022, 38(11): 775-779.

[5]

GAN Yanling, CHU Tongsheng, LIU Dianchang. Clinical analysis of 43 cases with leprosy reaction in leprosy multidrug therapy [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(6): 343-346.

[6]

ZHOU Jie, LI Jiao, YANG Rongjie, GUO Yun. Update of the treatment for severe adverse drug eruption [J]. China Journal of Leprosy and Skin Diseases, 2020, 36(9): 566-570.

[7]

TANG Yanli, SHEN Liling, ZHU Lu, YU Xiaobing. Borderline lepromatous leprosy with type I leprosy reaction: a case report [J]. China Journal of Leprosy and Skin Diseases, 2020, 36(4): 232-233.

[8]

YIN Lijiao, LONG Heng, SHEN Lianfa, YU Xiufeng, TAN Fuyue, YANG Yunyou, JI Liting. Type II leprosy reaction nodular erythematosis: a case report [J]. China Journal of Leprosy and Skin Diseases, 2020, 36(2): 101-103.

[9]

LI Haiying, ZENG Chenglong, WANG Shengchun, FENG Ting, ZHU Cansheng, MAO Weihua. Drug resistance test in 88 patients with gonorrhea [J]. China Journal of Leprosy and Skin Diseases, 2019, 35(7): 406-408.

[10]

LI Yang, SU Xiaohong. Drug resistance loci in Mycoplasma Genitalium and treatment [J]. China Journal of Leprosy and Skin Diseases, 2018, 34(4): 246-249.

[11]

[12]

ZHU Bangyong, LI Wei, DUAN Jiajun, ZHANG Jie, WEI Jiangping, ZHOU Zhiguang, HUANG Geng, TANG Zhongshu, CHEN Yujian, CAO Juan, GAN Quan, HUANG Yinjie.

PDF (PC)